Hong Dan and energy mixture combined with clinical observation of improvement of

[wlsqfjaru]

Hong Dan and energy mixture combined with clinical observation of improvement of coronary circulation
 
 
DI, a C. And can slow the progress of coronary artery disease, significantly reduce cardiovascular events or coronary heart disease mortality. Lower cholesterol levels can slow the progress of coronary artery disease, coronary artery disease to subside. 【Based IDl one: the higher the level obtained after treatment of patients benefit even more. Lipid levels on the basis of HMG-CoA reductase inhibitors reduce the Medical Forum in May 2003 Volume 24, lO percentage of lipids have significant impact. So. In the design and analysis of clinical trials related to treatment must be addressed. 4HMG-CoA-RI role of clinical side effects, but also show some minor side effects. Mainly as gastrointestinal reactions. Nausea,You are not allowed to view links. Register or Login, diarrhea, constipation,You are not allowed to view links. Register or Login, dizziness, headache, rash, myalgia, etc., may also occur transaminase, alkaline phosphatase, creatine kinase level rise. Side-effects theory has two aspects. First, as mevalonate is the impact of inhibition; mevalonate metabolism is cholesterol, the main end product, multi-terpene alcohols, and coenzyme Q. As we all know, cholesterol is the cell membrane and precursors of certain hormones, more terpene alcohol is a component of glycoproteins, coenzyme Q is the transmission of mitochondrial electron transport body. Plays an important physiological role. In the case of the normal therapeutic dose F,You are not allowed to view links. Register or Login, HM (;-CoA-Rl on the formation and role of these compounds do not have a meaningful impact. Second, the direct effect of the drugs themselves; there are several side effects are worth noting: medication patients with more than one year, about 1.9 of the patients, elevated aminotransferases, but returned to normal after drug withdrawal; the treatment of elevated creatine kinase occasionally there are cases, this fine Chu prompted serious adverse drug combination This clinical carefully considered when combination therapy. HM (;-CoA-RI represents a new class of lipid-lowering drugs. these drugs are characterized for the cause,You are not allowed to view links. Register or Login, a significant effect, less side effects and well tolerated. by inhibition of HMG-CoA reductase and block or reduce cholesterol synthesis. IDI receptor stimulation increases,You are not allowed to view links. Register or Login, the effective removal of body II) I. hyperlipidemia treated with these drugs can greatly reduce the disease, while coronary heart disease and the incidence of myocardial infarction and mortality. The discovery of such drugs, lipid-lowering drug is a long time to find a breakthrough.